Haben Ghermazien
Pulse Biosciences (United States)(US)
Publications by Year
Research Areas
Adenosine and Purinergic Signaling, Nanoplatforms for cancer theranostics, Monoclonal and Polyclonal Antibodies Research, Receptor Mechanisms and Signaling, Radiopharmaceutical Chemistry and Applications
Most-Cited Works
- → Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment(2010)843 cited
- → Selective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal Cancer(2015)191 cited
- → Developmental Switch in the Contribution of Presynaptic and Postsynaptic NMDA Receptors to Long-Term Depression(2007)175 cited
- → Lysyl oxidase-like-2 promotes tumour angiogenesis and is a potential therapeutic target in angiogenic tumours(2013)90 cited
- → Abstract 1476: A therapeutic antibody that inhibits CD73 activity by dual mechanisms(2016)12 cited
- → Abstract C076: Clinical pharmacokinetic/pharmacodynamic relationship for AB598, a large molecule inhibitor of CD39(2025)
- → 184 Tumor biomarker analysis of anti-CD39 monoclonal antibody AB598 in a first-in-human phase I trial in patients with advanced solid tumors(2025)
- → Abstract B024: The clinical benefit from treatment of advanced MSS mCRC with the adenosine 2a/2b antagonist etrumadenant is associated with adenosine-mediated T-cell exclusion and enhancement of the effectiveness of immunotherapy(2026)
- → Abstract 4120: Depletion of tissue-resident B cells by a CD20xCD3 IgM bispecific T cell engager in cynomolgus monkeys demonstrates effective tissue penetration and potent target cell killing(2023)